Surgical Innovation Milestone: PCS and PatchClamp Partnership Featured in Industry Publications
The PatchClamp experimental lab space at PCS. Shown in image: Scott Thielman, (left) CTO of PCS; Gina Longman, PCS senior project manager; David Desmarais (next to equipment), PCS senior mechanical engineer; Joe Piper (seated with smartphone), PatchClamp board member; and Dr. Marc Mayberg, PatchClamp founder.
Product Creation Studio is proud to announce that our groundbreaking collaboration with PatchClamp Medtech is now being featured in Informa Markets' prestigious MD+DI and DesignNews publications. This in-depth article, authored by our CTO Scott Thielman, showcases how our partnership transformed a neurosurgeon's clinical challenge into a revolutionary dural repair solution that has progressed through NIH SBIR-funded preclinical testing with promising results.
About the Feature Article
Scott's piece takes readers behind the scenes of the innovation journey that unfolded in our Seattle labs, where our engineering team worked alongside Dr. Marc Mayberg to address a critical limitation in minimally invasive neurosurgery. The article explores how this collaboration led to a breakthrough approach to dural repair that has successfully secured NIH SBIR grant funding, demonstrated positive preclinical data, and now supports an ongoing animal testing program.
Key Insights for Surgical Innovation Teams
For medical device innovators and corporate venture teams seeking development partners, our PatchClamp collaboration demonstrates several valuable principles:
Laboratory-based collaboration accelerates funding success By bringing clinical expertise directly into our engineering environment, we created a uniquely productive space where concepts could be rapidly prototyped, tested, and refined. This approach not only compressed timelines but also strengthened the technical package that helped secure competitive NIH SBIR funding.
Systematic testing builds confidence for preclinical advancement Our team developed specialized testing apparatus that precisely simulated surgical conditions, enabling methodical evaluation that generated compelling preclinical data. These positive results have since supported progression to animal testing—a critical milestone in the development pathway.
Multidisciplinary engagement drives breakthrough thinking The continuous interplay between clinical expertise and engineering perspectives fostered creative problem-solving that transcended traditional approaches, leading to innovations with demonstrated performance in preclinical evaluation.
Strategic development enhances commercialization pathways Our systematic approach to prototype development, validation, and preclinical data generation has created a solid foundation for PatchClamp's continued advancement toward market.
Why This Partnership Matters
Among the surgical innovations we've helped develop, PatchClamp exemplifies how the right engineering partnership can dramatically accelerate progress from concept to preclinical validation. With positive test data now supporting ongoing animal studies, this technology continues to build compelling evidence for investors and strategic partners.
We invite you to read the full article to explore how our collaborative approach transformed a neurosurgeon's insight into a technology that's demonstrating real-world potential through systematic preclinical evaluation.
The PatchClamp story showcases our commitment to partnering with visionary clinicians and entrepreneurs to navigate the complex journey from clinical insight through funding milestones to validation success. We look forward to continuing this partnership and welcome conversations with other innovators seeking similar development support.
Read the full feature in Informa Markets' publications
Product Creation Studio specializes in transforming innovative concepts into market-ready products across medical, consumer, and industrial sectors. For more information on our medical device development services, visit productcreationstudio.com.